We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Caristo's Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one of Oxford's most exciting companies.
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Take a glimpse into the future with startups emerging from OUI’s incubator.
OUI, Bioescalator and the Oxford Trust team up to showcase the University's facilities to the Oxford ecosystem.
The 2023 Spotlight on Spinouts report once again underlines Oxford’s leading position in spinout creation. The report underlines Oxford Science Enterprises’ positive impact on Oxford’s spinout community, while investments into Oxford spinouts remain high, despite UK-wide downturn.
Meet Terri Adams, the local glassblower designing the trophies for the upcoming Jamie Ferguson Chemistry Awards.
The University of Oxford partners with top universities and investors to agree terms which will greatly increase the UK’s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
A statistical analysis of 650 UK spinouts between 2010 and 2021 shows that the university proportion of equity share has a limited effect on multiple fundraising factors including the probability of spinouts raising equity, the amount of funding raised, and the market valuation of a spinout after it has received funding.
